shuxuetong

09/01/2012 - "Conclusions from this review may have a high risk of bias because of the low quality of the researches, hence it was not adequate to draw any reliable conclusions about the efficacy of Shuxuetong injection in progressive ischaemic stroke. "
09/01/2012 - "Randomized controlled trials (RCTs) and quasi randomized controlled trials (quasi-RCTs), which focused on treating patients with progressive ischaemic stroke using Shuxuetong injection were identified from Cochrane library, Medline, EMbase, CBM database, CNKI database, VIP database and Wanfang database. "
09/01/2012 - "To assess the clinical efficacy and safety of Shuxuetong injection against progressive ischaemic stroke. "
09/01/2012 - "[Systematic review of Shuxuetong injection for progressive ischaemic stroke]."
01/01/2020 - "To describe the design of the Shuxuetong injection for prevention of recurrence in acute ischaemic stroke with embolism mechanisms. "

03/01/2021 - "The present study aimed to investigate the effects of Shuxuetong (SXT) injection on VC and osteoporosis. "
03/01/2021 - "Shuxuetong injection simultaneously ameliorates dexamethasone-driven vascular calcification and osteoporosis."

01/01/2022 - "Compared with the model group, the neurological function score and cerebral infarction volume of the Shuxuetong treatment group were significantly different. "
08/28/2020 - "Effects of shuxuetong injection for cerebral infarction: A protocol for systematic review and meta-analysis."
09/01/2013 - "[Based on propensity score methods analysis of outcomes of parenterally administered shuxuetong in treatment of cerebral infarction]."
09/01/2013 - "Patients with cerebral infarction crowd using parenterally administered Shuxuetong were a mostly elderly population, with an average age of 66. "
09/01/2013 - "Patients receiving parenterally administered Shuxuetong for the treatment of cerebral infarction were included. "

03/01/2021 - "Shuxuetong injection simultaneously ameliorates dexamethasone-driven vascular calcification and osteoporosis."

10/01/2011 - "To evaluate the efficacy of Tuina and Chinese patent drug Shuxuetong injection in preventing patients undergoing total knee arthroplasty from deep venous thrombosis and in functional rehabilitation. "
10/01/2011 - "[Effects of Tuina and Chinese patent drug Shuxuetong injection on deep venous thrombosis and functional rehabilitation after total knee arthroplasty]."
10/01/2011 - "Tuina combined with Shuxuetong injection treatment can prevent deep venous thrombosis in patients with rheumatoid arthritis after total knee arthroplasty."